PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
5 hedge funds and large institutions have $1.96M invested in PureTech Health in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
24% more capital invested
Capital invested by funds: $1.58M → $1.96M (+$376K)
0.18% more ownership
Funds ownership: 0.39% → 0.58% (+0.18%)
0% more funds holding
Funds holding: 5 → 5 (0)
Top Buyers
| 1 |
Millennium Management
New York
|
+$765K |
| 2 |
DP
Diadema Partners
Morristown,
New Jersey
|
+$8.37K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
1
Pentwater Capital Management
Naples,
Florida
| $1.04M | – | – | – |
|
|
2
Millennium Management
New York
| $883K | +$765K | +44,090 | +286% |
|
|
PAP
3
Persistent Asset Partners
Hong Kong
| $26.1K | – | – | – |
|
|
DP
4
Diadema Partners
Morristown,
New Jersey
| $11.3K | +$8.37K | +482 | +6% |
|
5
UBS Group
Zurich,
Switzerland
| $297 | – | – | – |
|
PRTC Hedge Fund Activity: Q1 2026 in Review
5 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q1 2026, worth a combined $1.96M — up 24% from $1.58M a quarter earlier.
Fund positioning in PRTC was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, adding an estimated $765K.
- 5 institutional investors held PureTech Health (PRTC) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $1.96M of PureTech Health stock for Q1 2026, up 24% quarter-over-quarter.
- 0 funds opened new PureTech Health positions in Q1 2026 and 0 closed out.
- The largest PureTech Health buyer in Q1 2026 was Millennium Management, an estimated $765K added.
Based on aggregated 13F filings for Q1 2026.